Last Updated: June 25, 2026

CLINICAL TRIALS PROFILE FOR EVZIO (AUTOINJECTOR)

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for EVZIO (AUTOINJECTOR)

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00534378 ↗	Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector	Completed	U.S. Army Office of the Surgeon General	Phase 1	2006-07-01	Purpose of the study is to determine midazolam's safety and dose-linearity when delivered intramuscularly via an autoinjector. The proposed initial treatment dosage for seizures induced by exposure to nerve agents.
NCT00809146 ↗	Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications	Completed	Medical University of South Carolina	Phase 3	2009-06-01	The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗	Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 3	2009-06-01	The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗	Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications	Completed	University of California, San Francisco	Phase 3	2009-06-01	The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗	Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications	Completed	Robert Silbergleit	Phase 3	2009-06-01	The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00828204 ↗	Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects	Completed	Biogen	Phase 3	2009-01-01	The primary objective of the study was to evaluate the safe and effective use of the single-use autoinjector for the intramuscular (IM) delivery of liquid Avonex® (interferon beta-1a) in participants with multiple sclerosis (MS).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for EVZIO (AUTOINJECTOR)

Condition Name

Chart
Table

Condition Name for EVZIO (AUTOINJECTOR)
Intervention	Trials
Healthy	15
Healthy Volunteers	6
Rheumatoid Arthritis	6
Multiple Sclerosis	4
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for EVZIO (AUTOINJECTOR)
Intervention	Trials
Arthritis, Rheumatoid	7
Arthritis	7
Psoriasis	5
Multiple Sclerosis	5
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for EVZIO (AUTOINJECTOR)

Trials by Country

Map
Table

Trials by Country for EVZIO (AUTOINJECTOR)
Location	Trials
United States	313
Canada	26
Japan	25
Germany	12
United Kingdom	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for EVZIO (AUTOINJECTOR)
Location	Trials
Florida	25
Texas	22
California	19
Arizona	15
Missouri	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for EVZIO (AUTOINJECTOR)

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for EVZIO (AUTOINJECTOR)
Clinical Trial Phase	Trials
PHASE3	3
PHASE1	11
Phase 4	3
[disabled in preview]	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for EVZIO (AUTOINJECTOR)
Clinical Trial Phase	Trials
Completed	51
RECRUITING	9
Not yet recruiting	7
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EVZIO (AUTOINJECTOR)

Sponsor Name

Chart
Table

Sponsor Name for EVZIO (AUTOINJECTOR)
Sponsor	Trials
Eli Lilly and Company	11
Amgen	7
AstraZeneca	4
[disabled in preview]	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for EVZIO (AUTOINJECTOR)
Sponsor	Trials
Industry	80
Other	9
NIH	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.